rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    OCGN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Ocugen Inc. stock falls Monday, underperforms market
      Nov 16MarketWatchOCGN
      Ocugen Eyes 2027 Trial Results and FDA Filing for Lead Gene Therapy
      Nov 12Yahoo FinanceOCGN
      Ocugen at stifel 2026 healthcare conference: late-stage gene therapy push
      Nov 12Investing.comOCGNSF
      Ocugen Inc. stock rises Wednesday, still underperforms market
      Nov 11MarketWatchOCGN
      Ocugen licenses gene therapy OCU400 to Celairis for Asia-Pacific
      Nov 10Investing.comOCGN
      Ocugen and Celairis Therapeutics Enter into Exclusive License Agreement for OCU400 in Australia, New Zealand, and ASEAN
      Nov 10Yahoo FinanceOCGN
      Ocugen's Q3 Earnings Match Estimates, Revenues Beat, Stock Rises
      Nov 5Yahoo FinanceOCGN
      Ocugen Inc. stock rises Wednesday, outperforms market
      Nov 4MarketWatchOCGN
      Ocugen Inc (OCGN) Q3 2026 Earnings Call Highlights: Three Gene Therapy Programs Reach Phase 3 ...

      Ocugen Inc (OCGN) advances all three late-stage modifier gene therapy programs into Phase 3 with key data readouts expected in 2027, backed by $84.6 million in cash and new licensing deals.

      Nov 4Yahoo FinanceOCGN
      Ocugen Q3 Earnings Call Highlights
      Nov 4Yahoo FinanceOCGN
      Ocugen, Inc. Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinanceOCGN
      Ocugen (OCGN) Q3 2026 Earnings Call Transcript
      Nov 4The Globe and MailOCGN
      Earnings call transcript: Ocugen tops Q3 2026 estimates as shares rise 9%
      Nov 4Investing.comOCGN
      Ocugen Q3 2026 Earnings Call Transcript
      Nov 4BenzingaOCGN
      Ocugen earnings beat by $0.05, revenue topped estimates
      Nov 4Investing.comOCGN
      Ocugen Inc. stock falls Thursday, underperforms market
      Oct 29MarketWatchOCGN
      Ocugen to Participate in Upcoming November Investor and Industry Conferences
      Oct 29Yahoo FinanceOCGN
      Ocugen Inc. stock rises Wednesday, outperforms market
      Oct 28MarketWatchOCGN
      Ocugen Inc. stock rises Tuesday, outperforms market
      Oct 27MarketWatchOCGN
      Ocugen Inc. stock falls Monday, underperforms market
      Oct 26MarketWatchOCGN
      Ocugen Inc. stock falls Thursday, underperforms market
      Oct 22MarketWatchOCGN
      Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4
      Oct 22Yahoo FinanceOCGN
      Ocugen Inc. stock rises Tuesday, outperforms market
      Oct 20MarketWatchOCGN
      Ocugen Inc. stock falls Friday, underperforms market
      Oct 16MarketWatchOCGN
      Ocugen Inc. stock falls Wednesday, underperforms market
      Oct 14MarketWatchOCGN
      Ocugen Signs MENA Licensing Deal for OCU400
      Oct 14Yahoo FinanceOCGN
      Ocugen licenses retinitis pigmentosa gene therapy to MENA region
      Oct 14Investing.comOCGN
      Ocugen CEO Shankar Musunuri sells $499,691 of company stock
      Oct 14Investing.comOCGN
      Ocugen Inc. stock falls Tuesday, underperforms market
      Oct 13MarketWatchOCGN
      Ocugen Inc. stock falls Friday, underperforms market
      Oct 9MarketWatchOCGN
      Ocugen Inc. stock falls Thursday, underperforms market
      Oct 8MarketWatchOCGN
      Ocugen appoints general manager for new European affiliate
      Oct 6Investing.comOCGN
      Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate
      Oct 6Yahoo FinanceOCGN
      Transcript: Ocugen Q2 2026 Earnings Conference Call - Ocugen (NASDAQ:OCGN)

      Ocugen (NASDAQ:OCGN) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data.

      Oct 6BenzingaOCGN
      Ocugen Inc. stock rises Monday, outperforms market
      Oct 5MarketWatchOCGN
      Ocugen Inc. stock rises Friday, outperforms market
      Oct 2MarketWatchOCGN
      Ocugen Inc. stock falls Thursday, underperforms market
      Oct 1MarketWatchOCGN
      Analysts Offer Insights on Healthcare Companies: Quince Therapeutics (QNCX), Vir Biotechnology (VIR) and Ocugen (OCGN)

      Detailed price information for Ocugen Inc (OCGN-Q) from The Globe and Mail including charting and trades.

      Oct 1The Globe and MailOCGNQNCXVIR
      Ocugen Inc. stock falls Wednesday, underperforms market
      Sep 30MarketWatchOCGN
      Ocugen to Participate in Upcoming Scientific Conferences
      Sep 30Yahoo FinanceOCGN
      Ocugen Inc. stock rises Tuesday, outperforms market
      Sep 29MarketWatchOCGN
      Analysts Conflicted on These Healthcare Names: Ocugen (OCGN), Aveanna Healthcare Holdings (AVAH) and Universal Health (UHS)

      Detailed price information for Universal Health Services (UHS-N) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailAVAHOCGN
      Analysts Are Bullish on These Healthcare Stocks: Legend Biotech (LEGN), Ocugen (OCGN)

      Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailJAZZLEGNOCGN
      H.C. Wainwright raises Ocugen stock price target on Bahamas approval
      Sep 28Investing.comOCGN
      Ocugen Inc. stock rises Friday, outperforms market
      Sep 25MarketWatchOCGN
      Ocugen Eyes Global Access For Gene Therapy After Bahamas Boost — First Eye Disorder Patient Could Be Treated Within 90 Days

      Ocugen is building an international pathway for OCU400 ahead of key Phase 3 data and a planned U.S. regulatory filing next year.

      Sep 25Yahoo FinanceOCGN
      Ocugen receives provisional approval for gene therapy in Bahamas
      Sep 25Investing.comOCGN
      Ocugen Gets Provisional Approval for OCU400 in Bahamas

      Ocugen (OCGN) said Friday that its drug, OCU400, received provisional approval and priority designat

      Sep 25Yahoo FinanceOCGN
      Ocugen Stockholders Approve Meeting Adjournment for Share Increase

      Detailed price information for Ocugen Inc (OCGN-Q) from The Globe and Mail including charting and trades.

      Sep 24The Globe and MailOCGN
      Ocugen Inc. stock falls Wednesday, underperforms market
      Sep 23MarketWatchOCGN

      This is the newest page. Registered accounts read further back.